Literature DB >> 35662865

Con: Patients With Acute-on-Chronic Liver Failure Should Not Receive Priority on the Waiting List.

Nadim Mahmud1, K Rajender Reddy1.   

Abstract

Content available: Audio Recording.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID： 35662865      PMCID： PMC9135147          DOI： 10.1002/cld.1193

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  9 in total

1.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Shiv Kumar Sarin; Ashish Kumar; John A Almeida; Yogesh Kumar Chawla; Sheung Tat Fan; Hitendra Garg; H Janaka de Silva; Saeed Sadiq Hamid; Rajiv Jalan; Piyawat Komolmit; George K Lau; Qing Liu; Kaushal Madan; Rosmawati Mohamed; Qin Ning; Salimur Rahman; Archana Rastogi; Stephen M Riordan; Puja Sakhuja; Didier Samuel; Samir Shah; Barjesh Chander Sharma; Praveen Sharma; Yasuhiro Takikawa; Babu Ram Thapa; Chun-Tao Wai; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2008-11-20       Impact factor: 6.047

2.  High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease.

Authors:  K Rajender Reddy; Jacqueline G O'Leary; Patrick S Kamath; Michael B Fallon; Scott W Biggins; Florence Wong; Heather M Patton; Guadalupe Garcia-Tsao; Ram M Subramanian; Leroy R Thacker; Jasmohan S Bajaj
Journal:  Liver Transpl       Date:  2015-07       Impact factor: 5.799

3.  Early post-transplant survival: Interaction of MELD score and hospitalization status.

Authors:  Therese Bittermann; George Makar; David S Goldberg
Journal:  J Hepatol       Date:  2015-04-07       Impact factor: 25.083

Review 4.  Acute-on-Chronic Liver Failure.

Authors:  Vicente Arroyo; Richard Moreau; Rajiv Jalan
Journal:  N Engl J Med       Date:  2020-05-28       Impact factor: 91.245

5.  Incidence and Mortality of Acute-on-Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis.

Authors:  Nadim Mahmud; David E Kaplan; Tamar H Taddei; David S Goldberg
Journal:  Hepatology       Date:  2019-03-20       Impact factor: 17.425

6.  Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.

Authors:  Therese Bittermann; Nadim Mahmud; Ethan M Weinberg; K Rajender Reddy
Journal:  Transplantation       Date:  2022-03-24       Impact factor: 5.385

7.  Hyponatremia and mortality among patients on the liver-transplant waiting list.

Authors:  W Ray Kim; Scott W Biggins; Walter K Kremers; Russell H Wiesner; Patrick S Kamath; Joanne T Benson; Erick Edwards; Terry M Therneau
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

8.  Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS).

Authors:  Luca S Belli; Christophe Duvoux; Thierry Artzner; William Bernal; Sara Conti; Paolo A Cortesi; Sophie-Caroline Sacleux; George-Philippe Pageaux; Sylvie Radenne; Jonel Trebicka; Javier Fernandez; Giovanni Perricone; Salvatore Piano; Silvio Nadalin; Maria C Morelli; Silvia Martini; Wojciech G Polak; Krzysztof Zieniewicz; Christian Toso; Marina Berenguer; Claudia Iegri; Federica Invernizzi; Riccardo Volpes; Vincent Karam; René Adam; François Faitot; Liane Rabinovich; Faouzi Saliba; Lucy Meunier; Mickael Lesurtel; Frank E Uschner; Costantino Fondevila; Baptiste Michard; Audrey Coilly; Magdalena Meszaros; Domitille Poinsot; Andreas Schnitzbauer; Luciano G De Carlis; Roberto Fumagalli; Paolo Angeli; Vincente Arroyo; Rajiv Jalan
Journal:  J Hepatol       Date:  2021-05-02       Impact factor: 25.083

9.  Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.

Authors:  Ruben Hernaez; Yan Liu; Jennifer R Kramer; Abbas Rana; Hashem B El-Serag; Fasiha Kanwal
Journal:  J Hepatol       Date:  2020-06-10       Impact factor: 25.083
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.